Impact of metabolic dysfunction-associated steatotic liver disease on hepatocellular carcinoma risk in autoimmune hepatitis. Lim J, Kim YJ, Kim S, Shim JH, et al. PLoS One 2025;20:e0325066.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lim J, Kim YJ, Kim S, Shim JH, et al. Impact of metabolic dysfunction-associated steatotic liver disease on hepatocellular carcinoma risk in autoimmune hepatitis. PLoS One 2025;20:e0325066.
PMID: 40694545